Year-end Sale % OFF 
Abstract
(1) Background: For any antibacterial oral formulation to be successful, it must present effects in the presence of biofilms. Therefore, our aim is to analyze the drug release and the antibiofilm effects of a semi-solid formulation containing chlorhexidine (CHX) in the presence of pathogenic biofilms. (2) Methods: The biofilms of Streptococcus mutans (n = 6) or Porphyromonas gingivalis (n = 3) were formed for 6 and 4 days, respectively, being exposed to: 1) a CHX system or 2) vehicle control without CHX. A group without treatment was included as negative control. The acidogenicity, CHX quantification and bacterial viability were determined. A dissolution assay in a buffer and culture medium in the absence of bacteria was also performed. (3) Results: Although the CHX quantification in the culture medium of both biofilms was lower compared to the buffer (p < 0.05) and the culture medium in the absence of bacteria, the CHX system was able to display antibiofilm effects until 96 h for the S. mutans biofilms (p < 0.05) and 72 h for the P. gingivalis biofilms (p < 0.05). (4) Conclusions: The experimental formulation is able to extend chlorhexidine effects, even in challenging conditions such as in the presence of bacteria, allowing the in vitro control of cariogenic biofilms for 4 days and periodontopathogenic biofilms for 3 days.
Highlights
Biofilm is the major etiological factor for the development of dental caries [1] and is intimately associated with the advancing lesions of periodontitis [2]
(3) Results: the chlorhexidine gluconate (CHX) quantification in the culture medium of both biofilms was lower compared to the buffer (p < 0.05) and the culture medium in the absence of bacteria, the CHX system was able to display antibiofilm effects until 96 h for the S. mutans biofilms (p < 0.05) and 72 h for the P. gingivalis biofilms (p < 0.05)
We evaluated the antimicrobial effects produced by this formulation using two pathogenic biofilm models, one representative of dental caries and the other for periodontitis
Summary
Biofilm is the major etiological factor for the development of dental caries [1] and is intimately associated with the advancing lesions of periodontitis [2]. A notable feature of CHX is that it adheres to tooth and mucosal surfaces, which allows a prolonged antimicrobial activity inside the oral cavity [7]. The microenvironment produced by the biofilm could reduce the activity of potent agents such as CHX by preventing antimicrobial diffusion through the deeper layers of the matrix [9]. Based on these issues, the incorporation of CHX into a formulation capable of extending its antimicrobial effect might allow a wide spacing of dosages, optimizing the pharmacologic feature of this molecule and improving biofilm control
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
